News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
573,241 Results
Type
Article (11897)
Company Profile (170)
Press Release (561337)
Multimedia
Podcasts (14)
Webinars (12)
Section
Business (191350)
Career Advice (572)
Deals (29575)
Drug Delivery (31)
Drug Development (56776)
Employer Resources (40)
FDA (12153)
Job Trends (10774)
News (271092)
Policy (20863)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (3)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (4)
Academia (960)
Accelerated approval (32)
ADA (27)
Adcomms (1)
Allergies (130)
Alliances (41343)
ALS (134)
Alzheimer's disease (1200)
Antibody-drug conjugate (ADC) (339)
Approvals (12956)
Artificial intelligence (649)
ASCO (169)
Autoimmune disease (264)
Automation (66)
Bankruptcy (279)
Belgium (9)
Best Places to Work (8893)
BIO (42)
Biologics (28)
BIOSECURE Act (4)
Biosimilars (159)
BioSpace Insights (50)
Biotechnology (109)
Bispecific (8)
Bladder cancer (166)
Brain cancer (43)
Breast cancer (599)
Cancer (4501)
Cardiovascular disease (298)
Career advice (488)
Career pathing (14)
CAR-T (214)
CDC (4)
CDMO (61)
Celiac Disease (1)
Cell therapy (614)
Cervical cancer (48)
Clinical research (51674)
Collaboration (1891)
Commercialization (22)
Compensation (1635)
Complete response letters (41)
COVID-19 (1091)
CRISPR (92)
CRO (1)
C-suite (1051)
Cystic fibrosis (94)
Data (6854)
Decentralized trials (3)
Denatured (12)
Depression (121)
Dermatology (123)
Diabetes (457)
Diagnostics (5961)
Digital health (60)
Diversity (6)
Diversity, equity & inclusion (16)
Drug discovery (262)
Drug pricing (35)
Drug shortages (7)
Duchenne muscular dystrophy (188)
Earnings (79442)
Editorial (10)
Employer branding (2)
Employer resources (40)
Events (100001)
Executive appointments (949)
Eye disease (2)
FDA (15691)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (1)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (1371)
Gene editing (166)
Generative AI (39)
Gene therapy (437)
GLP-1 (453)
Government (1485)
Grass and pollen (4)
Guidances (332)
Healthcare (12712)
Hematology (105)
HIV (67)
Huntington's disease (25)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (77)
Immunology and inflammation (124)
Immuno-oncology (71)
Indications (199)
Infectious disease (1337)
Inflammatory bowel disease (155)
Inflation Reduction Act (4)
Influenza (110)
Intellectual property (296)
Interviews (81)
IPO (13839)
IRA (6)
Job creations (2285)
Job search strategy (419)
JPM (7)
Kidney cancer (18)
Kidney disease (64)
Labor market (19)
Layoffs (102)
Leadership (12)
Legal (5624)
Licensing (29)
Liver cancer (52)
Longevity (30)
Lung cancer (627)
Lung diease (9)
Lymphoma (299)
Machine learning (49)
Management (15)
Manufacturing (941)
Marketing (14)
MASH (131)
Medical affairs (2)
Medical device (12188)
Medtech (12437)
Mergers & acquisitions (17068)
Metabolic disorders (950)
mRNA (95)
Multiple sclerosis (123)
Multispecific (1)
NASH (4)
Netherlands (6)
Neurodegenerative disease (281)
Neuropsychiatric disorders (47)
Neuroscience (2271)
Neurotech (1)
NextGen: Class of 2026 (4492)
Non-profit (1636)
Now hiring (8)
Obesity (329)
Opinion (76)
Ovarian cancer (193)
Pain (233)
Pancreatic cancer (242)
Parkinson's disease (259)
Partnered (27)
Patents (579)
Patient advocacy (1)
Patient recruitment (622)
Patient selection (25)
Peanut (39)
People (47785)
Peptides (17)
Pharmaceutical (35)
Pharmacy benefit managers (19)
Phase 1 (16435)
Phase 2 (22838)
Phase 3 (16016)
Pipeline (9605)
Policy (51)
Postmarket research (1753)
Preclinical (6982)
Press Release (47)
Prostate cancer (238)
Psychedelics (15)
Radioligand (1)
Radiopharmaceuticals (249)
Rare diseases (719)
Real estate (4104)
Recruiting (14)
Regenerative medicine (9)
Regulatory (17931)
Reports (31)
Research institute (1037)
Resumes & cover letters (89)
Rett syndrome (48)
RNA editing (11)
RSV (56)
Schizophrenia (116)
Series A (234)
Series B (176)
Service/supplier (7)
Sickle cell disease (72)
Special edition (1)
Spinal muscular atrophy (104)
Sponsored (27)
Startups (2479)
State (1)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (94)
Switzerland (1)
Tariffs (9)
The Weekly (2)
Vaccines (476)
Venture capital (29)
Weight loss (137)
Wet AMD (1)
Women's health (122)
Worklife (4)
Date
Today (107)
Last 7 days (476)
Last 30 days (1855)
Last 365 days (22820)
2026 (17569)
2025 (22994)
2024 (27175)
2023 (31197)
2022 (40794)
2021 (44222)
2020 (41962)
2019 (32632)
2018 (24227)
2017 (23437)
2016 (22327)
2015 (28603)
2014 (24639)
2013 (20918)
2012 (23003)
2011 (23029)
2010 (22260)
Location
Africa (340)
Alabama (90)
Alaska (3)
Arizona (345)
Arkansas (13)
Asia (24572)
Australia (2947)
California (13669)
Canada (3749)
China (835)
Colorado (599)
Connecticut (512)
Delaware (311)
Europe (45621)
Florida (2092)
Georgia (462)
Hawaii (4)
Idaho (60)
Illinois (1041)
India (97)
Indiana (594)
Iowa (25)
Japan (500)
Kansas (119)
Kentucky (45)
Louisiana (43)
Maine (43)
Maryland (1395)
Massachusetts (9189)
Michigan (393)
Minnesota (766)
Mississippi (6)
Missouri (147)
Montana (22)
Nebraska (17)
Nevada (140)
New Hampshire (76)
New Jersey (3193)
New Mexico (27)
New York (3278)
North Carolina (1645)
North Dakota (11)
Northern California (6845)
Ohio (407)
Oklahoma (24)
Oregon (28)
Pennsylvania (2537)
Puerto Rico (26)
Rhode Island (45)
South America (608)
South Carolina (93)
South Dakota (1)
Southern California (5695)
Tennessee (170)
Texas (2328)
United States (46300)
Utah (433)
Vermont (2)
Virginia (221)
Washington D.C. (53)
Washington State (1075)
West Virginia (2)
Wisconsin (153)
Wyoming (2)
573,241 Results for "chf solutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
May 26, 2026
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
Press Releases
Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon
June 9, 2026
·
4 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
July 23, 2026
·
24 min read
Press Releases
Repligen Completes Acquisition of BioLife Solutions
October 6, 2026
·
3 min read
Press Releases
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Revenue of $2.5 Million, Up 27% Year-Over-Year
October 8, 2026
·
6 min read
Press Releases
NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
August 30, 2026
·
6 min read
Press Releases
Alithea Genomics Closes CHF 6.9 M Seed Round, Using Proceeds to Unlock Industrial-Scale RNA-seq for Primary Drug Screening and Toxicology
March 4, 2026
·
3 min read
Press Releases
Bachem Plans to Build a Large-Scale Production Facility in Sisslerfeld
Ad hoc announcement pursuant to Art. 53 LR • The next phase of the greenfield project in Sisslerfeld (Eiken, Switzerland) will be implemented as part of a strategic collaboration. • Total investment amounts to more than CHF 500 million. • Start of commercial production at the new site is expected in 2030.
July 21, 2026
·
2 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
1 of 57,325
Next